HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of HIKAL ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹78 Cr |
| Mar2023 | ₹160 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹84 Cr |
How is Consolidated Net Profit of HIKAL Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | -11.20 | |
| Mar2024 | ₹78 Cr | -51.16 | |
| Mar2023 | ₹160 Cr | 20.55 | |
| Mar2022 | ₹133 Cr | 57.68 | |
| Mar2021 | ₹84 Cr | - | |
Compare Consolidated Net Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,823.0 Cr | -6.9% | 20.4% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -6.9% |
20.4% |
-31.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses